ABVC BioPharma, Inc. ABVC
1.02 USD +0.05 (+5.28%)
At closeNov 9, 2026, 4:00 PM EST
1.02 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
0.9401 Day range 1.07
0.707 52-week range 3.06
- YTD
- -52.11%
- 1 year
- -64.95%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.15M | -4.71M | -6.77M | -15.11M | -11.71M | |
| -7.91M | -4.90M | -7.79M | -16.42M | -12.84M | |
| -0.39 | -0.42 | -1.80 | -5.19 | -5.10 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.33M | 863.82K | 716.78K | 1.39M | 6.57M | |
| 21.06M | 7.54M | 7.78M | 9.58M | 13.70M | |
| 7.76M | 6.82M | 6.53M | 6.34M | 4.83M | |
| 3.47M | 2.43M | 2.60M | 3.05M | 3.11M | |
| 11.11M | 1.23M | 1.55M | 3.10M | 8.84M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -2.99M | -1.81M | -4.19M | -7.40M | -7.60M | |
| -1.21M | 0 | -360.19K | -1.72M | -805.97K | |
| 4.64M | 1.98M | 3.87M | 4.01M | 10.00M | |
| -5.79K | 0 | -21.20K | -119.69K | -17.50K | |
| 463.17K | 147.03K | -674.95K | -5.17M | 1.56M |